Israel Infinity leads financing round for Nicast

Israel Infinity Venture Capital invested an estimated $5 million.

Nicast has completed a financing round led by Israel Infinity Venture Capital, which invested an estimated $5 million. Israel Infinity will initially invest $1 million. The round will remain open to more investors.

Founded in 1995, Nicast develops new vascular products, including artery grafts, and coated stents, based on new nano-scale manufacturing technology. TechnoPlus Ventures (TASE:TNPV) and Azritech Fund invested $2 million in Nicast in 2000.

Nicast's first product, a vascular implant, is in the advanced development stage. The implant acts like natural tissue and is accepted by the body, thus avoiding common transplant complications. Company sources have said in recent months that Nicast has been negotiating strategic agreements with leading companies.

Published by Globes [online] - www.globes.co.il - on March 3, 2004

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
MORE FROM GLOBES
Twitter Facebook Linkedin RSS Newsletters גלובס